Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force
- Malaz Boustani, MD, MPH;
- Britt Peterson, MD, MPH;
- Laura Hanson, MD, MPH;
- Russell Harris, MD, MPH; and
- Kathleen N. Lohr, PhD
-
From Indiana University School of Medicine, Indianapolis, Indiana; University of New Mexico School of Medicine, Albuquerque,
New Mexico; and University of North Carolina School of Medicine, Chapel Hill, and RTI International, Research Triangle Park,
North Carolina.
-
Appendix (Figure 1). KQ = key question. Analytic framework for screening for dementia.
-
Appendix (Figure 2). RCT = randomized, controlled trial. Selection of articles for key question 1: direct evidence.
-
Appendix (Figure 3). Selecting articles for key question 2: prevalence of undiagnosed dementia.
-
Appendix (Figure 4). Selecting articles for key question 3: accuracy of screening tests.
-
Appendix (Figure 5). RCT = randomized, controlled trial. Selecting articles for key question 4: efficacy of pharmacologic treatment.
-
Appendix (Figure 6). RCT = randomized, controlled trial. Selecting articles for key question 5: efficacy of nonpharmacologic treatment.
-
Appendix (Figure 7). RCT = randomized, controlled trial. Selecting articles for key question 6: interventions for planning.
-
Appendix (Figure 8). Selecting articles for key questions 7 and 8: harms of screening and treatment.
- Copyright ©2004 by the American College of Physicians
-
Ann Intern Med
June 3, 2003
vol. 138
no. 11
927-937